7,4′‐dimethoxy‐3‐hydroxyflavone, a protease‐activated receptor 4 (PAR4) inhibitor with antioxidant activity, ameliorates diabetic endothelial dysfunction

Documenti analoghi

• Direct neuronal protection by the protease‐activated receptor PAR4 antagonist ML354 after experimental stroke in mice
  di: Michael Fleischer, et al.
  Pubblicazione: (2024)
• Ginsenoside Rh4 prevents endothelial dysfunction as a novel AMPK activator
  di: Jiawei Zhang, et al.
  Pubblicazione: (2024)
• Hand–foot skin reaction as a positive prognostic factor in vascular endothelial growth factor receptor‐tyrosine kinase inhibitor treatment
  di: I‐Hsin Huang, et al.
  Pubblicazione: (2026)
• Rhynchophylline as an agonist of sirtuin 3 ameliorates endothelial dysfunction via antagonizing mitochondrial damage of endothelial progenitor cells
  di: Lin Lin, et al.
  Pubblicazione: (2025)
• Fatty acid binding protein 3 activates endothelial adhesion of circulating monocytes and impairs endothelial angiogenesis
  di: Yen‐Wen Wu, et al.
  Pubblicazione: (2025)